Mike Plante struggled with his weight for years, but within six months of starting with the injection drug semaglutide, a medication for diabetes that's also being used for weight-loss ... obstructive ...
Zepbound, a drug approved by the FDA, has been shown to reduce the severity of obstructive sleep apnea in obese adults, ...
5h
Eli Lilly and Novo Nordisk are likely to introduce its popular injectable drugs semaglutide and tirzepatide in India in 2025.
The U.S. Food and Drug Administration (FDA) has approved Zepbound, a prescription weight-loss medication, as the first drug ...
Ozempic has gotten most of the name recognition associated with weight-loss drugs, it's not the only drug in this category ...
This time last year, people were still bickering about whether Novo Nordisk's Wegovy and Eli Lilly & Co.'s Zepbound represented a shortcut to losing weight or a medical breakthrough. But with reams of ...
The FDA has declared an end to the shortage of a popular obesity drug. The implications for consumers are complicated.
By aiding weight loss, Zepbound can improve symptoms of obstructive sleep apnea (OSA) in people with obesity — but CPAP ...
A specific class of anti-inflammatory drugs can help children avoid a debilitating complication of Crohn's disease, a new study shows.
GLP-1 receptor agonist weight loss drugs can negatively interact with eating disorder psychopathology and treatment in ...
Mike Plante struggled with his weight for years, but within six months of starting with the injection drug semaglutide, a medication for diabetes that's also being used for weight-loss, he's down 65 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback